1. Home
  2. CRGX

CRGX

CARGO Therapeutics Inc.

Logo CARGO Therapeutics Inc.

as 04-24-2024 3:31pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Founded: 2021 Country:
N/A
Employees: N/A City: SAN MATEO
Market Cap: 755.4M IPO Year: 2023
Target Price: $29.67 AVG Volume (30 days): 309.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -16.53 EPS Growth: N/A
52 Week Low/High: $13.14 - $33.92 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of CARGO Therapeutics Inc. (CRGX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Third Rock Ventures V, L.P. CRGX 10% Owner Nov 14 '23 Buy $15.00 1,333,333 $19,999,995.00 1,807,119 SEC Form 4
Samsara BioCapital GP, LLC CRGX 10% Owner Nov 14 '23 Buy $15.00 666,666 $9,999,990.00 4,121,689 SEC Form 4